Table 1.

Percentage of sites accurately classified by optical imaging for each pathologic grade

Pathology grade
Mild dysplasia
Normal (%)Histopathology (%)IHC stratified (%)Mod. Dysplasia–Cancer (%)
AFI alone76656797
HRME alone71657392
AFI + HRME (MMIS)98358795

NOTE: Data are presented for sites with mild dysplasia by standard histopathology considered “abnormal,” and also following stratification of those mild dysplasia sites by biomarker status (p63 considered “normal,” p63+ considered abnormal).